News
To prevent dominance by an acknowledged adversary, the National Security Commission on Emerging Biotechnology (NSCEB) calls for a two-track strategy that helps American companies innovate more quickly ...
Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio ...
KalVista's sebetralstat nears FDA approval as a first-in-class oral treatment for hereditary angioedema. Read here for an ...
United Therapeutics is building the Silver Spring public parking facility under a development agreement with Montgomery ...
Acknowledging the crucial role of start-ups in propelling India's biotech sector, Dr. Singh called for stronger handholding mechanisms, increased incubator support, and early-stage funding ...
AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...
Amid a massive reorganization of the federal healthcare infrastructure that has prompted pushback from biotech and healthcare ...
According to Tempest, its options include a partnership or licensing deal, as well as a merger or an acquisition.
"Kim and Bo each bring three decades of leadership experience in the biotechnology and pharmaceutical industry ... and ...
About Climb Bio, Inc. Climb Bio, Inc. is a clinical-stage biotechnology company developing ... substantial additional capital needed, on the timeline necessary, to continue development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results